Platelet Reactivity in Unstable Coronary Artery Disease

Summary

Unstable coronary artery disease (CAD) might be related to obstructions of coronary blood flow by platelet aggregates. In 121 men and 43 women admitted to the coronary care unit with suspected unstable CAD, blood samples for tests of platelet function were obtained within 24 hours after admission. Platelet reactivity was tested in vitro in platelet rich plasma as the aggregability towards ADP 1 μM and collagen 1 mg/ml and as the sensitivity to prostacyclin (PSP). The levels of beta-thrombo-globulin and platelet factor 4 were determined ex vivo in platelet poor plasma. Patients who developed a nontransmural myocardial infarction (n = 39) or had signs of myocardial ischemia at an exercise test performed within a week (n = 39) were considered to have unstable CAD while patients without signs of ischemia constituted the control group. In the acute phase the PSP was reduced in patients with unstable CAD without any difference between genders. The aggregability towards ADP was higher in women than men but otherwise there were no differences between groups or sexes in any other test in the acute phase. After 12 months there were no differences in PSP between the groups but women had a lower PSP than men. Thus, in the acute phase of unstable CAD, the platelet sensitivity to the inhibitory effects of prostacyclin was reduced which might contribute to the risk for further platelet aggregation, coronary occlusion and myocardial infarction.

Keywords

Unstable coronary artery disease - Nontransmural myocardial infarction - Exercise test - Platelet aggregation - Platelet sensitivity to prostacyclin - Beta-thromboglobulin - Platelet factor 4

• References

• 1 Ambrose JA, Winters SL, Stern A, Eng A, Teichholz LE, Gorlin R, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616
• 2 Davies MJ, Thomas AC. Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363-373
• 3 Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 1985; 71: 699-708
• 4 Maseri A, Chierchia S, L’Abbate A. Pathogenetic mechanisms underlying the clinical events associated with atherosclerotic heart disease. Circulation 1980; 62 (suppl) V 3-13
• 5 Rose GA, Blackburn H. Cardiovascular survey methods. Rose GA, Blackburn H. (eds.) WHO; Geneva: 1968
• 6 Gillman RF, Fortman SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and stroke. Prog Cardiol 1984; 108: 150-157
• 7 Swahn E, Areskog M, Wallentin L. Early exercise testing after coronary care for suspected unstable coronary artery disease - safety and diagnostic value. Eur Heart J 1986; 7: 594-601
• 8 Born GV, Cross MI. The aggregation of blood platelets. J Physiol 1963; 168: 178-195
• 9 Gormsen J, Nielsen DJ, Andersen AL. ADP-induced platelet aggregation in vitro in patients with ischemic heart disease and peripheral thrombo-atherosclerosis. Acta Med Scand 1977; 201: 509-513
• 10 Berglund U, von Schenck H, Wallentin L. Effects of ticlopidine on platelet function in men with stable angina pectoris. Thromb Haemostas 1985; 54: 808-812
• 11 Gallino A, Haeberli A, Baur HR, Straub PW. Fibrin formation and platelet aggregation in patients with severe coronary artery disease: relationship with the degree of myocardial ischemia. Circulation 1985; 72: 27-30
• 12 Mehta J, Mehta P. Comparison of platelet function during exercise in normal subjects and coronary artery disease patients: Potential role of platelet activation in myocardial ischemia. Am Heart J 1982; 103: 49-53
• 13 Berglund U, Lassvik C, Wallentin L. Effects of the platelet inhibitor Ticlopidine on exercise tolerance in stable angina pectoris. Eur Heart J. (in press)
• 14 Stratton JR, Malpass TW, Ritchie JL, Pfeifer MA, Harker LA. Studies of platelet factor 4 and beta-thromboglobulin release during exercise: lack of relationship to myocardial ischemia. Circulation 1982; 66: 33-43
• 15 Verheugt FW, Serruys PW, van Vliet H, Spijkers A, Hugenholtz PG. Intracoronary platelet release in patients with and without coronary artery disease. Thromb Haemostas 1983; 49: 28-31
• 16 Mathis PC, Wohl H, Wallach SR, Engler RL. Lack of release of platelet factor 4 during exercise-induced ischemia. N Engl J Med 1981; 304: 1275-1278
• 17 Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
• 18 Mehta P, Mehta J. Platelet function studies in coronary heart disease: VIII. Decreased platelet sensitivity to prostacyclin in patients with myocardial ischemia. Thromb Res 1980; April 1-15 18 (1-2) 273-277
• 19 Sinzinger H, Schernthaner G, Kaliman J. Sensitivity of platelets to prostaglandins in coronary heart disease and angina pectoris. Prostaglandins 1981; 22: 773-781
• 20 Sinzinger H, Kefalides A. Passive smoking severely decreases platelet sensitivity to antiaggregatory prostaglandins. Lancet 1982; 2: 392-393
• 21 Serneri NG, Fortini A, Lombardi A, Modesti PA, Abbate R, Gensini GF. Reduction in prostacyclin platelet receptors in active spontaneous angina. Lancet 1984; 13: 838-841
• 22 Mehta J, Mehta P, Feldman RL, Horalek C. Thromboxane release in coronary artery disease: Spontaneous versus pacing-induced angina. Am Heart J 1984; 107: 286-292
• 23 Serneri NG, Gensini GF, Abbate R, Prisco D, Rogasi PG, Laureano R, Casolo GC, Fantini F, Donato DM, Dabizzi RP. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina. Am Heart J 1985; 109: 732-737
• 24 Serneri NG, Masotti G, Poggesi L, Galanti G, Morettini A, Scarti L. Reduced prostacyclin production in patients with different manifestations of ischemic heart disease. Am J Cardiol 1982; 49: 1146-1150
• 25 Roper-Drewinko P, Drewinko B, Corrigan G, Johnston D, McCredie K, Freireich E. Standardization of platelet function tests. Am J Haematol 1981; 11: 183-203
• 26 Yamazaki H, Motomiya T, Sonoda M, Miyagawa N. Changes in platelet aggregability after ovariectomy. Thromb Haemostas 1979; 42: 1332-1339
• 27 Guiteras VP, Chaitman BR, Waters DD, Bourassa MG, Scholl J-M, Ferguson RJ, Wagniart P. Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. Circulation 1982; 65: 1465-1474
• 28 Weiner DA, Ryan TJ, McCabe CH, Kennedy JW, Schloss M, Tristani F, Chaitman BR, Fisher LD. Exercise stress testing. N Engl J Med 1979; 301: 230-235
• 29 Hung J, Chaitman BR, Lam J, Lesperance J, Dupras G, Fines P, Bourassa MG. Noninvasive diagnostic test choices for the evaluation of coronary artery disease in women: A multivariate comparison of cardiac fluoroscopy, exercise electrocardiography and exercise thallium myocardial perfusion scintigraphy. JACC 1984; 4: 8-16
• 30 Swahn E, Areskog M, Berglund U, Walfridsson H, Wallentin L. Predictive importance of clinical findings and a predischarge exercise test in suspected unstable coronary artery disease. Am J Cardiol. 1986 (in press)
• 31 Lewis HD, Davies JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwai SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983; 309: 396-403
• 32 Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH. Aspirin, sulfinpyrazone, or both in unstable angina. N Engl J Med 1985; 313: 1369-1375